6.1.2.9. radiotherapy t1 t2 disease. radiotherapy organ-preserving approach good results selected patients t1–2 lesions . given external radiotherapy minimum dose 60 gy eqd2 combined brachytherapy boost brachytherapy alone . brachytherapy studied lesions < 4 cm hence use limited tumours exceeding size. reported results best brachytherapy local control rates ranging 70–90% . american brachytherapy society groupe européen de curiethérapie-european society therapeutic radiation oncology consensus statement penile brachytherapy also reported good tumour control rates, acceptable morbidity, functional organ preservation penile brachytherapy stages t1 t2 disease . penile preservation rates 70–88% reported , overall penile conservation rates 87% 70% 5 10 years. pulsed-dose-rate brachytherapy used interchangeably traditional low-dose rate 15% local recurrences reported one series . high-dose rate brachytherapy introduced experience still limited [164-169]. panel’s sr identified 21 studies evaluating efficacy radiotherapy management primary tumour men penile cancer. total 1,222 men low-, pulse-, high-dose rate brachytherapy circumcision . cumulative mean 5-year rfrs 78.6% (861/1,096) brachytherapy 55.2% (37/67) ebrt. four studies (including ebrt brachytherapy cohorts) reported rfrs per disease stage, 5-year rfrs t1 ranging 59–94%, 50–67% t2, 17–77% t3 disease [167,170-172]. studies comparing surgical treatment radiotherapy, results surgery slightly better. meta-analysis comparing surgery brachytherapy, 5-year os local control rates 76–84% surgery 73–79% brachytherapy, respectively . organ preservation rate brachytherapy 74% difference survival. local recurrence radiotherapy salvaged surgery . specific complications radiotherapy penile cancer urethral stenosis (20–35%), glans necrosis (10–20%) late fibrosis corpora cavernosa . brachytherapy, meatal stenosis reported occur 40% cases much lower contemporary series 73 patients 6.6%. series, 2.6% patients reported pain sexual intercourse 5.3% dysuria follow-up 5 years. penile amputation necrosis necessary 6.8% patients . functional outcome radiotherapy often reported. one report, 17/18 patients normal erections treatment maintained treatment . minimum 3 years (median 5.9) follow-up brachytherapy treatment, 29/34 patients (median age 63 years) answered self-reporting questionnaire. urethral dilatation necessary 30% patients, self-catheterisation 13%; erectile dysfunction mild 70% continued maintain sexual activity, qol good.